Click here for slides on this topic

PCSK9 inhibitors

Injectable class of monoclonal antibodies that work by inactivating a protein in the liver called proprotein convertase subtilisin kexin 9 (PCSK9).
The following content matched the glossary term: PCSK9 inhibitors

Alirocumab Significantly Reduces LDL-C in High-Risk Patients in ODYSSEY FH I & FH II


The PCSK9 inhibitor, alirocumab, significantly reduced LDL-C in high-risk patients with heterozygous FH in ODYSSEY FH I & FH II; from ESC 2015

Slide Library Results

Search Results for: PCSK9 inhibitors Slides Found: 2
PCSK9 Inhibitors for Residual CV Risk NLA Cholesterol Guidelines | CCMD
FH Treatment & Management PCSK9 NLA Cholesterol Guidelines | CCMD